Search

Displaying results 1631 - 1640 of 10000 in total
  1. Drug

    Tropatepine

    go.drugbank.com/drugs/DB13252
    Experimental

    Tropatepine has been used in France for its antiparkinsons activities .

    Categories: Heterocyclic Compounds, 3-Ring
  2. Drug

    Proxibarbal

    go.drugbank.com/drugs/DB13253
    Approved

    Proxibarbal is a derivative of barbiturates, which has been used to treat migraines.

    Categories: Heterocyclic Compounds, 1-Ring
  3. Drug

    Clothiapine

    go.drugbank.com/drugs/DB13256
    Approved

    Clothiapine has been approved in European countries and is an atypical antipsychotic, shown to be useful in some treatment-resistant patients.

    Categories: Heterocyclic Compounds, 3-Ring
  4. Drug

    Sitafloxacin

    go.drugbank.com/drugs/DB13261
    Investigational

    Categories: 4-Quinolones, Heterocyclic Compounds, 2-Ring
  5. Drug

    Ritiometan

    go.drugbank.com/drugs/DB13267
    Approved

    Ritiometan is a nasal spray which is marketed by the name Nécyrane in France. It is indicated for use in viral rhinitis/ the common cold.

  6. Drug

    Acetarsol

    go.drugbank.com/drugs/DB13268
    ApprovedWithdrawn

    Acetarsol, with the molecular formula N-acetyl-4-hydroxy-m-arsanilic acid, is a pentavalent arsenical compound with antiprotozoal and antihelmintic properties.

  7. Drug

    Wood creosote

    go.drugbank.com/drugs/DB13271
    Investigational

    Mixtures: ยาเม็ดตกเบ็ด 4.
  8. Drug

    Clorindione

    go.drugbank.com/drugs/DB13275
    Experimental

    Clorindione is a vitamin K antagonist, which may be useful to decrease prothrombin levels in humans.

    Categories: Vitamin K Antagonists
  9. Drug

    Benziodarone

    go.drugbank.com/drugs/DB13277
    ApprovedWithdrawn

    Benziodarone is a uricostatic and a uricosuric agent which is sold also under the name Amplivex-Labaz. It is used in the treatment of gout [A175630].

    Categories: Heterocyclic Compounds, 2-Ring
  10. Drug

    Etilamfetamine

    go.drugbank.com/drugs/DB13285
    Experimental

    Etilamfetamine is also known as N-ethylamphetamine and is in the Canadian Legislation - The Controlled Drugs and Substances Act, and is a Schedule 1 controlled drug.